Literature DB >> 16140379

Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies.

Gregory R Moe1, Apurva Dave, Dan M Granoff.   

Abstract

The capsular polysaccharide of Neisseria meningitidis group B (MBPS) is a polymer of alpha (2-->8) N-acetyl neuraminic acid, which is chemically identical to polysialic acid (PSA) expressed in human tissues. Antibodies from mice immunized with a MBPS-protein conjugate vaccine in which N-acetyl groups have been replaced by propionyl groups (N-Pr MBPS) can be bactericidal and show minimal or no cross-reactivity with human PSA. To investigate the molecular basis for antigen recognition, we cloned and sequenced the variable region (V) genes of five bactericidal anti-N-Pr MBPS murine mAbs and produced computer models of the combining sites. The results were compared to those reported in the literature for two autoreactive anti-MBPS. The V region genes of the anti-N-Pr MBPS mAbs and the anti-MBPS autoreactive mAbs are derived from a limited set of germline V, J, and D genes. However, the anti-N-Pr MBPS mAbs are more mutated than the anti-MBPS mAbs and the former use V-D-J editing that introduces arginine in H-CDR3. Models of the respective combining sites indicate that the anti-MBPS or anti-N-Pr MBPS mAbs that react with host PSA have relatively wide and shallow grooves with a high overall positive charge, consistent with recognition of extended helical polysaccharide structures recognized by the autoreactive mAbs. In contrast, anti-N-Pr MBPS mAbs that do not react with host PSA contain pockets and deep clefts that are consistent with recognition of discrete structural features of individual residues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140379      PMCID: PMC2245894          DOI: 10.1016/j.molimm.2005.07.033

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  39 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Multiple sequence alignment with the Clustal series of programs.

Authors:  Ramu Chenna; Hideaki Sugawara; Tadashi Koike; Rodrigo Lopez; Toby J Gibson; Desmond G Higgins; Julie D Thompson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis.

Authors:  H J Jennings; R Roy; F Michon
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

4.  Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

Authors:  J Finne; M Leinonen; P H Mäkelä
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

5.  Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants.

Authors:  R E Mandrell; W D Zollinger
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

Review 6.  Vaccine prevention of meningococcal disease, coming soon?

Authors:  S L Morley; A J Pollard
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

7.  Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.

Authors:  W D Zollinger; R E Mandrell; J M Griffiss; P Altieri; S Berman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Immunological properties of monoclonal antibodies specific for meningococcal polysaccharides: the protective capacity of IgM antibodies specific for polysaccharide group B.

Authors:  C Moreno; J Hewitt; K Hastings; D Brown
Journal:  J Gen Microbiol       Date:  1983-08

9.  Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.

Authors:  H J Jennings; C Lugowski
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

10.  Autoimmune disease in NZB/BL mice. 3. Induction of membranous glomerulonephritis in young mice by the transplantation of spleen cells from old mice.

Authors:  R C Mellors
Journal:  J Exp Med       Date:  1966-06-01       Impact factor: 14.307

View more
  11 in total

1.  Specificity of the immune response to a modified group B meningococcal polysaccharide conjugate vaccine.

Authors:  Samuel Moore; Esmé K Farley; Peter C Fusco; Francis Michon
Journal:  Clin Vaccine Immunol       Date:  2006-11-01

2.  The expression profile of de-N-acetyl polysialic acid (NeuPSA) in normal and diseased human tissue.

Authors:  Taizo A Nakano; Lindsay M Steirer; Gregory R Moe
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

3.  Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever.

Authors:  Ying Peng; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  J Immunol       Date:  2012-10-10       Impact factor: 5.422

4.  Evidence for rosettes as an unrecognized stage in the life cycle of Leishmania parasites.

Authors:  David M Iovannisci; C Paul Plested; Gregory R Moe
Journal:  J Eukaryot Microbiol       Date:  2010-08-05       Impact factor: 3.346

5.  Effect of human serum on de-N-acetyl sialic acid epitope expression and antibody activity against N. meningitidis group B.

Authors:  Becca A Flitter; Jessica Y Ing; Gregory R Moe
Journal:  Vaccine       Date:  2010-07-15       Impact factor: 3.641

6.  Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against neisseria meningitidis groups B and C.

Authors:  Gregory R Moe; Tamara S Bhandari; Becca A Flitter
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

7.  Extracellular structure of polysialic acid explored by on cell solution NMR.

Authors:  Hugo F Azurmendi; Justine Vionnet; Lauren Wrightson; Loc B Trinh; Joseph Shiloach; Darón I Freedberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

8.  An antibody to de-N-acetyl sialic acid containing-polysialic acid identifies an intracellular antigen and induces apoptosis in human cancer cell lines.

Authors:  Lindsay M Steirer; Gregory R Moe
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

9.  Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant.

Authors:  Abel E Vasquez; Ricardo A Manzo; Daniel A Soto; Magaly J Barrientos; Aurora E Maldonado; Macarena Mosqueira; Anastasia Avila; Jorge Touma; Elsa Bruce; Paul R Harris; Alejandro Venegas
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 10.  Carbohydrate based meningococcal vaccines: past and present overview.

Authors:  Francesco Berti; Maria Rosaria Romano; Francesca Micoli; Roberto Adamo
Journal:  Glycoconj J       Date:  2021-04-27       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.